Highlights from the Week of 26th October – 02nd November in the world of pharma and healthcare!

Highlights from the week of 26th Oct - 02th Nov Pfizer ( FDA, Approval ) Pfizer's TALZENNA gains extended approval from FDA in combination with XTANDI to treat men with mAPMN/S prostate cancer and mHSPC Xbrane Biopharma ( FDA, Approval ) FDA approves Xbrane Biopharma's LUCAMZI, a biosimilar to LUCENTIS, for a cost-effective treatment option of wet AMD and other serious eye conditions Sun Pharma ( FDA, Approval ) FDA approves Sun Pharma's sBLA, ILUMYA, for the treatment of adults with active PsA INOVIO ( FDA, Accelerated Approval ) Inovio obtains FDA accelerated approval for VOCERYQ, indicated to reduce the frequency of surgeries in adults with RRP All logos and trademarks remain the intellectual properties of their respective owners

Connect with us

Please fill in the information below, and we'll get back to you.